Opaleye Management Inc. Cidara Therapeutics, Inc. Transaction History

Opaleye Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$1.48 - $2.35 $108,559 - $172,374	-73,351 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.7 $137,166 - $198,047	73,351 New	73,351 $148,000
Q4 2020 Feb 12, 2021	SELL	$1.99 - $3.25 $1.93 Million - $3.15 Million	-970,664 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.39 - $4.0 $154,413 - $258,432	64,608 Added 7.13%	970,664 $3.58 Million
Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $1.58 Million - $3.86 Million	906,056 New	906,056 $2.25 Million

Q2 2019 Aug 14, 2019	SELL	$1.49 - $2.94 $1.49 Million - $2.94 Million	-1,000,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.35 - $3.27 $470,000 - $654,000	-200,000 Reduced 16.67%	1,000,000 $2.65 Million
Q2 2018 Aug 14, 2018	BUY	$3.75 - $6.05 $4.5 Million - $7.26 Million	1,200,000 New	1,200,000 $6.24 Million

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $837M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.